Description: Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million ($2.99 million) and SEK 250 million ($29.99 million), the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB was founded in 1991 and based in Stockholm, Sweden.
Home Page: linc.se
Vasagatan 28
Stockholm,
111 20
Sweden
Phone:
46 8 58 71 18 12
Officers
| Name | Title |
|---|---|
| Mr. Karl Tobieson | Chief Executive Officer |
| Mr. Thomas Bergh | Chief Financial Officer |
Exchange: ST
Country: SE : Sweden
Currency: Swedish krone (kr)
| GIC Sector: | Industrials |
|---|---|
| GIC Group: | Commercial & Professional Services |
| GIC Industry: | Commercial Services & Supplies |
| GIC Sub-Industry: | Environmental & Facilities Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 6.5534 |
| Price-to-Book MRQ: | 1.0154 |
| Price-to-Sales TTM: | 2.9869 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2 |